Fund moves

Medtronic (MDT): Cullen Capital Management, LLC reduced its stake -39K shares

Cullen Capital Management, LLC reduced its stake in Medtronic, per its Q2 2026 13F.

2.59M
Shares reported · -39K vs prior quarter
2.0%
Disclosed portfolio weight
$203M
Reported value
Holdings as of
Jun 30, 2026
Filed
Aug 13, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. May 7, 2025CongressDisclosed partial sale of MDT — reported range $1,001 - $15,000
  2. Mar 27, 2026CongressDisclosed purchase of MDT — reported range $1,001 - $15,000
  3. Jul 8, 2026InsiderOfficer sold ~$258K of MDT shares in the open market
  4. Jul 30, 2026CongressDisclosed sale of MDT — reported range $1,001 - $15,000

What came next

  1. Aug 24, 2026CongressDisclosed sale of MDT — reported range $15,001 - $50,000
  2. Sep 1, 2026Company filing · Form 8-K · ResultsReported its results
  3. Sep 2, 2026FDARecall: Generic Name: MiniMed Go App Generic Name: MiniMed Go App Model/Catalog Number: MMT-8600 (iOS), MMT-8601 (Android) Software Version: Software version 1.2.1 Pro…
  4. Sep 4, 2026FDAFDA device clearance: ApexCut ™ Blade with Automated EM Tracking (187BL4012EM);ApexCut ™ Blade with Automated EM Tracking (187BL4040EM);ApexCut ™ Blade with Automated EM Tracking (1…
  5. Sep 8, 2026FDARecall: InterStim Percutaneous Extensions EXT 3560022 ISTM II PERC 3560022 EXT 3560030 ISTM MICRO PERC 3560030
  6. Sep 8, 2026FDARecall: InterStim SureScan MRI Leads 978A1 & 978B1: LEAD 978A128 ISTM MICRO 28CM SSMRI TINED 978A128 LEAD 978A133 ISTM MICRO 33CM SSMRI TINED 978A133 LEAD 978A141 ISTM…
  7. Sep 11, 2026FDARecall: CareLink Clinic, REF: MMT-7350
  8. Sep 15, 2026FDAFDA device clearance: LigaSure™ RAS Maryland Jaw Vessel Sealer/Divider, Nano-coated
  9. Sep 16, 2026InsiderOfficer sold ~$139K of MDT shares in the open market
  10. Sep 17, 2026FDAFDA device clearance: Protégé™ EverFlex™ Self-expanding Peripheral Stent System
  11. Sep 17, 2026FDARecall: OmniaSecure Model 3930M, LEAD 3930M74 74 CM DF4 MR 3930M74 LEAD 3930M79 79 CM DF4 MR 3930M79 The Medtronic OmniaSecure" Model 3930M lead is a steroid eluting,…
  12. Sep 24, 2026FDARecall: CareLink SmartSync Device Manager App, Model M01A02, Pulse generator, permanent, implantable
  13. Sep 24, 2026FDARecall: CareLink SmartSync, RF Head Patient Connector, Model 24967, Pulse generator, permanent, implantable
  14. Sep 24, 2026FDARecall: CareLink SmartSync Programmer, Model 24970A, Pulse generator, permanent, implantable
  15. Oct 15, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote (and 1 more item)“On October 15, 2026, the Board of Directors (the "Board") of Medtronic plc (the “Company”) approved the appointment of Michael Marinaro, Executive Vice President and President, Medical Surgical Portfolio, Americas, and Global Commercial Operations to the role of President, Medtronic, effective October 14, 2026.”
  16. Oct 15, 2026Insider · 2 peopleInsiders: 2 sales (~$5.8M)
  17. Oct 23, 2026FDAFDA device clearance: DLP PVC Left Heart Vent; DLP Malleable PVC Left Heart Vent; DLP Silicone Left Heart Vent
  18. Oct 29, 2026FDAFDA device clearance: Symmetrix™ PX Spinal System
  19. Oct 29, 2026FDAFDA device clearance: DLP™ Coronary Ostial Cannulae
  20. Nov 6, 2026FDAFDA device clearance: StealthStation™ S8 Cranial v2.3.0
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Medtronic

For Medtronic, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MDT page.

How this filing works

Explore the data

Common questions

What does this filing report about Medtronic (MDT) stock?

Cullen Capital Management, LLC reduced its stake in Medtronic, per its Q2 2026 13F. Now 2.59M shares, $203M reported value, 2.0% of disclosed portfolio.

When did it happen, and when was it made public?

Holdings as of: Jun 30, 2026. Filed: Aug 13, 2026.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Medtronic recently?

For Medtronic, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the MDT page.

Does this mean MDT stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Medtronic

Everything OQRO holds on this company is on its MDT page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data